Related Experiment Video
Updated: May 18, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p53 counteracts reprogramming by inhibiting mesenchymal-to-epithelial transition
R Brosh1, Y Assia-Alroy, A Molchadsky
1Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. ranbroshran@gmail.com
Inhibiting the p53-p21 pathway enhances somatic cell reprogramming by promoting mesenchymal-to-epithelial transition (MET). This discovery offers new strategies for improving therapeutic cell generation and understanding cell plasticity.
Area of Science:
- Cell Biology
- Developmental Biology
- Molecular Biology
Background:
- Somatic cell reprogramming holds therapeutic promise but is inefficient.
- Inhibiting the p53 tumor suppressor facilitates reprogramming by limiting proliferation and apoptosis.
- Mesenchymal-to-epithelial transition (MET) is crucial for fibroblast reprogramming.
Purpose of the Study:
- To investigate if p53 impedes reprogramming by affecting MET.
- To elucidate the mechanism by which p53 influences MET during reprogramming.
Main Methods:
- Investigated the role of p53 in MET during early reprogramming phases.
- Utilized transcriptome analysis to identify gene expression changes.
- Assessed the correlation between p53 activity and epithelial marker expression.
- Determined the involvement of p21 in p53's inhibitory effect on MET.
Main Results:
- p53 restricts MET during early reprogramming, primarily by inhibiting Klf4-mediated epithelial gene activation.
- Transcriptome analysis revealed Klf4 induces an epithelial gene signature in p53-deficient cells.
- E-Cadherin expression negatively correlates with p53 activity in mesenchymal cells.
- The p53-p21 axis mediates the inhibition of MET.
Conclusions:
- Inhibiting the p53-p21 axis promotes MET, making mesenchymal cells more receptive to reprogramming.
- This study reveals a novel mechanism of p53-mediated reprogramming restraint.
- Highlights p53's role in regulating cellular plasticity and reprogramming efficiency.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Somatic to iPS Cell Reprogramming
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

